RSV, and influenza leading to increased hospitalizations. The CDC notes a rise in illness across 40 states and predicts ...
Symptoms include congestion, cough, fever, and fatigue, with the loss of taste and smell now less common.Flu activity is high ...
Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...
Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...
The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...
Flu cases are surging across the commonwealth but for the youngest Pennsylvanians, another potentially dangerous respiratory ...
(HealthDay News) — Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more ...
Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED ...
Thurston County has recorded its first influenza-related death for the 2024-2025 flu season, according to a Friday news ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...
The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...
The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.